Author:
Kelly Thomas H.,Kazura Alessandra N.,Lommel Karen M.,Babalonis Shanna,Martin Catherine A.
Reference210 articles.
1. Achenbach, T. M. (1991). Integrative guide for the 1991 CBCL 14–18, YSR, and TRF profiles. Burlington, VT: University of Vermont Department of Psychiatry.
2. Adriani, W., Spijker, S., Deroche-Gamonet, V., Laviola, G., Le Moal, M., Smit, A. B., et al (2003). Evidence for enhanced neurobehavioral vulnerability to nicotine during periadolescence in rats. Journal of Neuroscience, 23(11), 4712–4716.
3. Aizenstein, M. L., Segal, D. S., & Kuczenski, R. (1990). Repeated amphetamine and fencamfamine: Sensitization and reciprocal cross-sensitization. Neuropsychopharmacology, 3, 283–290.
4. Andersen, S. L., & Navalta, C. P. (2004). Altering the course of neurodevelopment: A framework for understanding the enduring effects of psychotropic drugs. International Journal of Developmental Neuroscience, 22, 423–440.
5. Anthony, J. C., Warner, L. A., & Kessler, R. C. (1994). Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity Survey. Experimental and Clinical Psychopharmacology, 2, 244–268.